Antibody targeting of E3 ubiquitin ligases for receptor degradationHadir Marei, Felipe de Sousa e Melo, Jieyan He et al.|Nature|2022Cited by 254
Resiliency and Vulnerability in the HER2-HER3 Tumorigenic DriverDhara N. Amin, Mark M. Moasser, Natalia Sergina et al.|Science Translational Medicine|2010Cited by 185